CFLAR and Barrett esophagus: Nevertheless, our results demonstrate significantly elevated levels of PKC-δ, cIAP2, and FLIP in BE and EAC patients compared to normal esophageal tissues from obese patients pave the way to investigate the role of cIAP2, and FLIP in EAC and therapeutic potential of targeting these molecules.